Article
Patient and Family Resources for Living With Myelodysplastic Syndromes
Primarily a disease affecting older adults, myelodysplastic syndromes (MDS) are a class of incurable myeloid malignancies with variable clinical presentation, treatment recommendations, and prognoses. Although effective communication between healthcare professionals and patients and their caregivers is a significant part of optimizing clinical outcomes, studies have shown that all three frequently have an incomplete understanding of MDS, its therapeutic options, and the fact that MDS is a malignancy. In addition, the advanced age of the patient population, high frequency of comorbidities, and variability of disease outcomes based on risk status require consistent communication across a wide number and type of healthcare providers as well as an individualized approach to patient and caregiver education. This article discusses these challenges and provides a number of resources designed to help educate healthcare professionals, patients, and caregivers.
Jump to a section
References
Aubin, M., Vézina, L., Verreault, R., Fillion, L., Hudon, E., Lehmann, F., … Morin, D. (2011). Patient, primary care physician, and specialist expectations of primary care physician involvement in cancer care. Journal of General Internal Medicine, 27, 8-15. doi:10.1007/s11606-011-1777-7
Bejar, R., Levine, R., & Ebert, B. L. (2011). Unraveling the molecular pathophysiology of myelodysplastic syndromes. Journal of Clinical Oncology, 29, 504-515. doi:10.1200/JCO.2010.31.1175
Brown, V. A., Parker, P. A., Furber, L., & Thomas, A. L. (2011). Patient preferences for the delivery of bad news? The experience of a UK cancer centre. European Journal of Cancer Care, 20, 56-61. doi:10.1111/j.1365-2354.2009.01156.x
Carreca, I., & Balducci, L. (2009). Cancer chemotherapy in the older cancer patient. Urologic Oncology, 27, 633-642. doi:10.1016/j.urolonc.2009.08.006
Cheung, W. Y., Neville, B. A., Cameron, D. B., Cook, E. F., & Earle, C. C. (2009). Comparisons of patient and physician expectations for cancer survivorship care. Journal of Clinical Oncology, 27, 2489-2495. doi:10.1200/JCO.2008.20.3232
ClinicalTrials.gov. (2012). Search for clinical trials. Retrieved from http://www.clinicaltrials.gov/ct2/search
Cogle, C. R., Craig, B. M., Rollison, D. E., & List, A. F. (2011). Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: High number of uncaptured cases by cancer registries. Blood, 117, 7121-7125. doi:10.1182/blood-2011-02-337964
Dayyani, F., Conley, A. P., Strom, S. S., Stevenson, W., Cortes, J. E., Borthakur, G., … Garcia-Manero, G. (2010). Cause of death in patients with lower-risk myelodysplastic syndromes. Cancer, 116, 2174-2179. doi:10.1002/cncr.24984
Demakos, W., & Kurtin, S. (2011). Disease burden and treatment impact associated with myelodysplastic syndromes: Initial estimates [Abstract 354]. Leukemia Research, 35(Suppl. 1), S142.
Fujimori, M., & Uchitomi, Y. (2009). Preferences of cancer patients regarding communication of bad news: A systematic literature review. Japanese Journal of Clinical Oncology, 39, 201-216. doi:10.1093/jjco/hyn159
Garcia-Manero, G. (2011). Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 86, 490-498. doi:10.1002/ajh.22047/10.1002/ajh.22047
Greenberg, P. L., Attar, E., Bennett, J. M., Bloomfield, C. D., De Castro, C. M., Deeg, H. J., … National Comprehensive Cancer Network. (2011). NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic syndromes. Journal of the National Comprehensive Cancer Network, 9, 30-56.
Kurtin, S. (2010). Risk analysis in the treatment of hematological malignancies in the elderly. Journal of Advanced Practitioner in Oncology, 1, 119-129.
Kurtin, S. (2011). Current approaches to the diagnosis and management of myelodysplastic syndromes. Journal of the Advanced Practitioner in Oncology, 2(Suppl. 2), 7-18.
Kurtin, S. E., & Demakos, E. P. (2010). An update on the treatment of myelodysplastic syndromes [Online exclusive]. Clinical Journal of Oncology Nursing, 14, E29-E44. doi:10.1188/10.CJON.E24-E39
Life Beyond Limits. (2011). MDS treatment matters. Retrieved from http://www.mdslifebeyondlimits.org
Litton, G., Kane, D., Clay, G., Kruger, P., Belnap, T., & Parkinson, B. (2010). Multidisciplinary cancer care with a patient and physician satisfaction focus. Journal of Oncology Practice, 6, e35-e37. doi:10.1200/JOP.2010.000028
Ma, X., Does, M., Raza, A., & Mayne, S. T. (2007). Myelodysplastic syndromes: Incidence and survival in the United States. Cancer, 109, 1536-1542. doi:10.1002/cncr.22570
MDS Foundation. (2011). Home page. Retrieved from http://www.mds-foundation.org
National Comprehensive Cancer Network. (2011). NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic syndromes [v2.2011]. Retrieved from http://www.nccn.org/professionals/physician_gls/PDF/mds.pdf
National Marrow Donor Program. (2011). Be the match. Retrieved from http://marrow.org/Home.aspx
Protiere, C., Moumjid, N., Bouhnik, A. D., Le Corroller Soriano, A. G., & Moatti, J. P. (2011). Heterogeneity of cancer patient information-seeking behaviors. Medical Decision Making. Advance online publication. doi:10.1177/0272989X11415114
Rodin, G., Mackay, J. A., Zimmermann, C., Mayer, C., Howell, D., Katz, M., … Brouwers, M. (2009). Clinician-patient communication: A systematic review. Supportive Care in Cancer, 17, 627-644. doi:10.1007/s00520-009-0601-y
Sekeres, M. A. (2011). Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010. Journal of the National Comprehensive Cancer Network, 9, 57-63.
Sekeres, M. A., Maciejewski, J. P., List, A. F., Steensma, D. P., Artz, A., Swern, A. S., … Stone, R. (2011). Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: Results from an Internet-based survey. Oncologist, 16, 904-911. doi:10.1634/theoncologist.2010-0199